Kieran O'Kane, Chief Commercial Officer at BIODESIX INC (BDSX), sold 477 shares at $0.36 ($169) on 2025-05-12, disclosed to the SEC on 2025-05-13.
Seasonal sale ($169) by Chief Commercial Officer — this insider has traded BDSX in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.36 | 239 | $86 | 50.8% |
| 2 | $0.35 | 238 | $83 | 49.2% |
| Total | $0.36 avg | 477 | $169 | 100% |
| Filing → |
| BDSX | SELL | 2026-01-20 | $2K | — | Filing → |
| BDSX | SELL | 2025-11-13 | $191 | — | Filing → |
| BDSX | SELL | 2025-08-14 | $200 | — | Filing → |